跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
DBL AMIKACIN 500mg/2mL injection
Approved
STANDARD
DBL AMIKACIN 500mg/2mL injection
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
53aba18089c79c2b
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
53aba18089c79c2b
Product Name
DBL AMIKACIN 500mg/2mL injection
Artg Id
49945
Artg Name
DBL AMIKACIN 500mg/2mL (as sulfate) injection vial
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1994-09-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/e302c6a86a5126c3c3472eb1ccea8ecd.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/1e7083ad3001f5f2b94ca0005eca6b15.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
53aba18089c79c2b
Type
Standard
Back to TGA Approvals
DBL AMIKACIN 500mg/2mL injection - TGA Drug Approval Details